Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Manufacturer: APP

..

005715
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, Each
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, Each
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, Each
Manufacturer: APP (Shop the Brand)

Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, Each

Item Code: 005715
Mfg Part #: 63323-184-10
$119.99
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Folic Acid
Route of Administration Intravenous (IV), Intramuscular (IM), Subcutaneous (SC)
Strength 5 mg/mL
Volume 10 mL
Container Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature, Protect from Light
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Vitamin
Unit of Measure Each

Folic Acid Injection, USP is a sterile, nonpyrogenic solution of sodium folate (5 mg/mL) in Water for Injection, indicated for intramuscular (IM), intravenous (IV), or subcutaneous (SC) administration. Each 10 mL multiple dose vial delivers 50 mg of folic acid for parenteral treatment of megaloblastic anemias due to folate deficiency.

This prescription-only injectable is indicated when oral folate supplementation is inadequate or contraindicated—including cases associated with tropical or nontropical sprue, nutritional deficiency, pregnancy, infancy, or childhood. Manufactured by Fresenius Kabi USA, LLC, this USP-grade formulation supports erythropoiesis and nucleoprotein synthesis at the cellular level.

Key Benefits

  • Targeted Megaloblastic Anemia Treatment: Clinically indicated for folate-deficiency anemias, directly stimulating production of red blood cells, white blood cells, and platelets.
  • Triple-Route Flexibility: Approved for IM, IV, and SC administration, enabling use across a broad range of clinical scenarios and patient conditions.
  • Sterile, Nonpyrogenic Formulation: Manufactured to USP standards, ensuring a safe, pyrogen-free solution suitable for parenteral use.
  • Multi-Dose Vial Efficiency: Available as a 10 mL multiple dose vial (50 mg total / 5 mg per mL), supporting repeated clinical dosing from a single container.
  • Trusted Clinical Pedigree: ANDA-approved (ANDA089202) and marketed continuously since 2000 by Fresenius Kabi USA, a globally recognized injectable manufacturer.

Dosage and Administration

Parenteral routes (IM, IV, SC) are indicated when the condition is exceptionally severe or when gastrointestinal absorption is impaired or known to be unreliable.

  • Usual Therapeutic Dose (Adults and Children): Up to 1 mg daily. Resistant cases may require larger doses.
  • Maintenance — Infants: 0.1 mg per day.
  • Maintenance — Children Under 4 Years: Up to 0.3 mg per day.
  • Maintenance — Adults and Children 4+ Years: 0.4 mg per day.
  • Maintenance — Pregnant and Lactating Women: 0.8 mg per day; never less than 0.1 mg per day.
  • Special Populations: Patients with alcoholism, hemolytic anemia, anticonvulsant therapy, or chronic infection may require increased maintenance dosing.
  • Visual Inspection Required: Inspect for particulate matter and discoloration prior to administration.

Why Choose Folic Acid Injection, USP?

  • Parenteral Access When Oral Routes Fail: Ideal for patients with compromised GI absorption where oral folate supplementation is ineffective or unreliable.
  • Flexible Multi-Dose Format: The 10 mL vial (5 mg/mL) supports multiple clinical dosing events, reducing waste and improving workflow efficiency.
  • Broad Patient Coverage: Indicated across age groups—from infants to pregnant women—making it a versatile option for folate-deficiency management.

Warnings

  • Aluminum Toxicity Risk: This product contains aluminum. Prolonged parenteral use in patients with impaired renal function—especially premature neonates—may result in aluminum accumulation associated with CNS and bone toxicity. Aluminum intake exceeding 4–5 mcg/kg/day is associated with toxic tissue loading.
  • Benzyl Alcohol Hazard in Premature Infants: This product contains benzyl alcohol (15 mg/mL), which has been associated with fatal "Gasping Syndrome" in premature infants. Do not use in this population.
  • Not Appropriate for Pernicious Anemia Monotherapy: Folic acid alone is improper therapy for pernicious anemia or other megaloblastic anemias caused by Vitamin B₁₂ deficiency. Doses above 0.1 mg/day may mask hematologic signs while neurological deterioration continues.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, 10/Tray
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, 10/Tray
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, 10/Tray
Picture of Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, 10/Tray
Manufacturer: APP (Shop the Brand)

Folic Acid Injection 5 mg/mL, Multiple Dose Vial 10 mL, 10/Tray

Item Code: 009932
Mfg Part #: 63323-184-10
$1,016.37
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Folic Acid
Route of Administration Intravenous (IV), Intramuscular (IM), Subcutaneous (SC)
Strength 5 mg/mL
Volume 10 mL
Container Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature, Protect from Light
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Vitamin
Unit of Measure Each

Folic Acid Injection, USP is a sterile, nonpyrogenic solution of sodium folate (5 mg/mL) in Water for Injection, indicated for intramuscular (IM), intravenous (IV), or subcutaneous (SC) administration. Each 10 mL multiple dose vial delivers 50 mg of folic acid for parenteral treatment of megaloblastic anemias due to folate deficiency.

This prescription-only injectable is indicated when oral folate supplementation is inadequate or contraindicated—including cases associated with tropical or nontropical sprue, nutritional deficiency, pregnancy, infancy, or childhood. Manufactured by Fresenius Kabi USA, LLC, this USP-grade formulation supports erythropoiesis and nucleoprotein synthesis at the cellular level.

Key Benefits

  • Targeted Megaloblastic Anemia Treatment: Clinically indicated for folate-deficiency anemias, directly stimulating production of red blood cells, white blood cells, and platelets.
  • Triple-Route Flexibility: Approved for IM, IV, and SC administration, enabling use across a broad range of clinical scenarios and patient conditions.
  • Sterile, Nonpyrogenic Formulation: Manufactured to USP standards, ensuring a safe, pyrogen-free solution suitable for parenteral use.
  • Multi-Dose Vial Efficiency: Available as a 10 mL multiple dose vial (50 mg total / 5 mg per mL), supporting repeated clinical dosing from a single container.
  • Trusted Clinical Pedigree: ANDA-approved (ANDA089202) and marketed continuously since 2000 by Fresenius Kabi USA, a globally recognized injectable manufacturer.

Dosage and Administration

Parenteral routes (IM, IV, SC) are indicated when the condition is exceptionally severe or when gastrointestinal absorption is impaired or known to be unreliable.

  • Usual Therapeutic Dose (Adults and Children): Up to 1 mg daily. Resistant cases may require larger doses.
  • Maintenance — Infants: 0.1 mg per day.
  • Maintenance — Children Under 4 Years: Up to 0.3 mg per day.
  • Maintenance — Adults and Children 4+ Years: 0.4 mg per day.
  • Maintenance — Pregnant and Lactating Women: 0.8 mg per day; never less than 0.1 mg per day.
  • Special Populations: Patients with alcoholism, hemolytic anemia, anticonvulsant therapy, or chronic infection may require increased maintenance dosing.
  • Visual Inspection Required: Inspect for particulate matter and discoloration prior to administration.

Why Choose Folic Acid Injection, USP?

  • Parenteral Access When Oral Routes Fail: Ideal for patients with compromised GI absorption where oral folate supplementation is ineffective or unreliable.
  • Flexible Multi-Dose Format: The 10 mL vial (5 mg/mL) supports multiple clinical dosing events, reducing waste and improving workflow efficiency.
  • Broad Patient Coverage: Indicated across age groups—from infants to pregnant women—making it a versatile option for folate-deficiency management.

Warnings

  • Aluminum Toxicity Risk: This product contains aluminum. Prolonged parenteral use in patients with impaired renal function—especially premature neonates—may result in aluminum accumulation associated with CNS and bone toxicity. Aluminum intake exceeding 4–5 mcg/kg/day is associated with toxic tissue loading.
  • Benzyl Alcohol Hazard in Premature Infants: This product contains benzyl alcohol (15 mg/mL), which has been associated with fatal "Gasping Syndrome" in premature infants. Do not use in this population.
  • Not Appropriate for Pernicious Anemia Monotherapy: Folic acid alone is improper therapy for pernicious anemia or other megaloblastic anemias caused by Vitamin B₁₂ deficiency. Doses above 0.1 mg/day may mask hematologic signs while neurological deterioration continues.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Brands in this category
Picture for manufacturer American Regent
Picture for manufacturer Exela
Picture for manufacturer Hospira
Picture for manufacturer McGuff Pharmaceuticals
Picture for manufacturer Mylan

Featured Articles

McGuff’s Promise of Quality and Service

For over 50 years, we’ve been the trusted name in healthcare excellence. Medical practitioners can rely on us for quality products, fast deliveries, and superior service. We strive for customer satisfaction and maintaining that trust.

We at the McGuff Company, Inc. (McGuff) work very hard to provide you accurate and timely information on our website. However, it is your obligation to verify such information before using the products purchased from McGuff.

All information is provided “As-is” and may change without prior notice. McGuff does not make warranty or representation that the information contained on this site is accurate, current, or complete.

Any use of information by you is without recourse to McGuff and is at your own risk.

McGuff is in no way responsible for any damages whether direct, consequential, incidental, or otherwise suffered by you or others on your behalf as a result of using or relying upon such information for any purpose.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Folic Acid
Route of Administration Intravenous (IV), Intramuscular (IM), Subcutaneous (SC)
Strength 5 mg/mL
Volume 10 mL
Container Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature, Protect from Light
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Vitamin
Unit of Measure Each

Contact Us

McGuff Company is LegitScript Certified

Copyright © 2026 McGuff Company, Inc. All rights reserved.

For information on the duties and responsibilities of this web site, please read our privacy policy and our warning and disclaimer. Use of this website signifies your agreement to the Privacy Policy and Warning Disclaimer.

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President